EPISODE · Jun 7, 2022 · 32 MIN
"Dexcom is Preparing for the Future" CEO Kevin Sayer on G7, the international market, competitors and more
from Diabetes Connections | Type 1 Diabetes
Dexcom CEO Kevin Sayer joins Stacey from the American Diabetes Association's Scientific Sessions with new G7 information, a response to Abbott's Libre 3 approval, addressing rumors about acquiring another diabetes company and a lot more. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! ----- Episode Transcription Below (or coming soon!) Please visit our Sponsors & Partners - they help make the show possible! *Click here to learn more about OMNIPOD* *Click here to learn more about AFREZZA* *Click here to learn more about DEXCOM*
NOW PLAYING
"Dexcom is Preparing for the Future" CEO Kevin Sayer on G7, the international market, competitors and more
No transcript for this episode yet
Similar Episodes
Sep 29, 2023 ·76m
Sep 29, 2023 ·73m
Sep 29, 2023 ·72m
Sep 29, 2023 ·75m
Sep 29, 2023 ·75m
Sep 29, 2023 ·73m